US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

REVVITY INC

94.41

+0.25000.27%

Post-market: 94.410.00000.00%16:42 EDT

Volume:985.88K

Turnover:93.40M

Market Cap:11.13B

PE:40.17

High:95.64

Open:94.00

Low:92.86

Close:94.16

Loading ...

Overview Company News Filings

KeyBanc Adjusts Price Target on Revvity to $145 From $135, Keeps Overweight Rating

MT Newswires Live

KeyBanc Keeps Their Buy Rating on Revvity (RVTY)

Revvity Inc. Stock Underperforms Tuesday When Compared To Competitors

Revvity Inc. Stock Outperforms Competitors On Strong Trading Day

Press Release: Revvity to Hold Earnings Call on Monday, April 28, 2025

Revvity Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Evercore ISI Adjusts Revvity Price Target to $125 From $138, Maintains Outperform Rating

MT Newswires Live

Revvity Says FDA Approves Auto-Pure 2400 Liquid Handler for Tuberculosis Test

MT Newswires Live

Revvity announces FDA approval for Auto-Pure 2400 liquid handling platform

BRIEF-Revvity Secures FDA Approval For Improved Automated Latent Tuberculosis Test

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

THOMSON REUTERS

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Revvity Inc. Stock Outperforms Competitors Despite Losses On The Day

Becton Dickinson in talks with Thermo Fisher, Danaher to divest life sciences unit, FT reports

1 Healthcare Stock to Target This Week and 2 to Turn Down

Revvity Inc. Stock Underperforms Tuesday When Compared To Competitors

Revvity Inc. Stock Rises Monday, Still Underperforms Market

Revvity Stock Tumbles Despite Expanding Genomics England Alliance

Revvity Expands Alliance with Genomics England

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RVTY/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RVTY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RVTY\",,,,,undefined,":{"symbol":"RVTY","market":"US","secType":"STK","nameCN":"REVVITY INC","latestPrice":94.41,"timestamp":1750276800000,"preClose":94.16,"halted":0,"volume":985876,"hourTrading":{"tag":"盘后","latestPrice":94.41,"preClose":94.41,"latestTime":"16:42 EDT","volume":64885,"amount":6125792.85,"timestamp":1750279339456},"delay":0,"floatShares":117226798,"shares":117869660,"eps":2.350273,"marketStatus":"Closed Juneteenth National Independence Day","change":0.25,"latestTime":"06-18 16:00:00 EDT","open":94,"high":95.64,"low":92.86,"amount":93403928.07394,"amplitude":0.029524,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.350273,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750406400000},"marketStatusCode":7,"adr":0,"listingDate":-141681600000,"exchange":"NYSE","adjPreClose":94.16,"dividendRate":0.002966,"preHourTrading":{"tag":"盘前","latestPrice":94.5,"preClose":94.25,"latestTime":"09:19 EDT","volume":1151,"amount":108181.205484,"timestamp":1750252772523},"postHourTrading":{"tag":"盘后","latestPrice":94.41,"preClose":94.41,"latestTime":"16:42 EDT","volume":64885,"amount":6125792.85,"timestamp":1750279339456},"volumeRatio":0.992347,"impliedVol":0.4034,"impliedVolPercentile":0.788},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RVTY\",,,,,undefined,":{"symbol":"RVTY","floatShares":117226798,"roa":"2.03%","roe":"3.82%","lyrEps":2.202621,"volumeRatio":0.992347,"shares":117869660,"dividePrice":0.28,"high":95.64,"amplitude":0.029524,"preClose":94.16,"low":92.86,"week52Low":87.7,"pbRate":"1.46","psRate":"4.02","week52High":129.5,"institutionHeld":0.9781,"latestPrice":94.41,"eps":2.350273,"divideRate":0.002966,"volume":985876,"delay":0,"ttmEps":2.350273,"open":94,"prevYearClose":111.61,"prevWeekClose":93.53,"prevMonthClose":90.42,"prevQuarterClose":105.8,"fiveDayClose":96.07,"twentyDayClose":93.58,"sixtyDayClose":108.59},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RVTY\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526369512","title":"KeyBanc Adjusts Price Target on Revvity to $145 From $135, Keeps Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2526369512","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526369512?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:56","pubTimestamp":1744203397,"startTime":"0","endTime":"0","summary":"Revvity (RVTY) has an average rating of overweight and mean price target of $134.29, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RVTY"],"gpt_icon":0},{"id":"2526336896","title":"KeyBanc Keeps Their Buy Rating on Revvity (RVTY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2526336896","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526336896?lang=en_us&edition=fundamental","pubTime":"2025-04-09 16:28","pubTimestamp":1744187300,"startTime":"0","endTime":"0","summary":"In a report released today, Paul Knight from KeyBanc maintained a Buy rating on Revvity (RVTY – Research Report). The company’s shares closed yeste...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/keybanc-keeps-their-buy-rating-on-revvity-rvty?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/keybanc-keeps-their-buy-rating-on-revvity-rvty?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVTY"],"gpt_icon":0},{"id":"2526825484","title":"Revvity Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2526825484","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526825484?lang=en_us&edition=fundamental","pubTime":"2025-04-09 05:17","pubTimestamp":1744147020,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Revvity Inc.  slid 4.54% to $91.79 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 1.57% to 4,982.77 and Dow Jones Industrial Average  falling 0.84% to 37,645.59.Revvity Inc. closed 29.12% below its 52-week high of $129.50, which the company achieved on November 6th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Danaher Corp.  fell 3.31% to $174.64, IDEXX Laboratories Inc.  fell 4.74% to $361.04, and Agilent Technologies Inc.  fell 4.15% to $99.29.Trading volume  eclipsed its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 8, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVTY"],"gpt_icon":0},{"id":"2525741960","title":"Revvity Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2525741960","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525741960?lang=en_us&edition=fundamental","pubTime":"2025-04-08 05:16","pubTimestamp":1744060560,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Revvity Inc.  rose 1.39% to $96.16 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.23% to 5,062.25 and Dow Jones Industrial Average  falling 0.91% to 37,965.60.The stock's rise snapped a two-day losing streak.Revvity Inc. closed 25.75% short of its 52-week high of $129.50, which the company achieved on November 6th.The stock outperformed some of its competitors Monday, as Danaher Corp.  fell 0.63% to $180.62, IDEXX Laboratories Inc.  fell 3.74% to $378.99, and Agilent Technologies Inc.  rose 0.57% to $103.59.Trading volume  eclipsed its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 7, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVTY"],"gpt_icon":0},{"id":"2524225634","title":"Press Release: Revvity to Hold Earnings Call on Monday, April 28, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524225634","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524225634?lang=en_us&edition=fundamental","pubTime":"2025-04-03 20:04","pubTimestamp":1743681840,"startTime":"0","endTime":"0","summary":"Revvity, Inc. , today announced that it will release its first quarter 2025 financial results prior to market open on Monday, April 28, 2025. The Company will host a conference call the same day at 8:00 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call.To access the call, a live audio webcast will be available on the Investors section of the Company's website.At Revvity, \"impossible\" is inspiration, and \"can't be done\" is a call to action. Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what's possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.With 2024 revenue of more than $2.7 billion","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVTY"],"gpt_icon":0},{"id":"2524441033","title":"Revvity Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2524441033","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524441033?lang=en_us&edition=fundamental","pubTime":"2025-04-03 05:18","pubTimestamp":1743628680,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Revvity Inc.  rose 2.31% to $106.72 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.67% to 5,670.97 and the Dow Jones Industrial Average  rising 0.56% to 42,225.32.Revvity Inc. closed 17.59% below its 52-week high of $129.50, which the company reached on November 6th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Danaher Corp.  rose 2.38% to $205.16, IDEXX Laboratories Inc.  rose 1.83% to $426.25, and Agilent Technologies Inc.  rose 1.70% to $115.99.Trading volume  remained 312,744 below its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 2, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Jour","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVTY"],"gpt_icon":0},{"id":"2524978934","title":"Evercore ISI Adjusts Revvity Price Target to $125 From $138, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2524978934","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524978934?lang=en_us&edition=fundamental","pubTime":"2025-04-02 22:35","pubTimestamp":1743604522,"startTime":"0","endTime":"0","summary":"Revvity (RVTY) has an average rating of overweight and mean price target of $135.59, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RVTY"],"gpt_icon":0},{"id":"2524949947","title":"Revvity Says FDA Approves Auto-Pure 2400 Liquid Handler for Tuberculosis Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2524949947","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524949947?lang=en_us&edition=fundamental","pubTime":"2025-04-02 21:31","pubTimestamp":1743600687,"startTime":"0","endTime":"0","summary":"Revvity (RVTY) said Wednesday the US Food and Drug Administration has approved the company's Auto-Pure 2400 liquid handling platform with the T-SPOT.TB diagnostic test for latent tuberculosis.The Auto-Pure 2400 platform was launched outside the US in 2024, Revvity said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4121","BK4585","RVTY"],"gpt_icon":0},{"id":"2524679544","title":"Revvity announces FDA approval for Auto-Pure 2400 liquid handling platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2524679544","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524679544?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:06","pubTimestamp":1743595578,"startTime":"0","endTime":"0","summary":"Revvity (RVTY) announced that the FDA has approved the Auto-Pure 2400 liquid handling platform with the T-SPOT.TB test. Initially launched outside ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revvity-announces-fda-approval-for-auto-pure-2400-liquid-handling-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revvity-announces-fda-approval-for-auto-pure-2400-liquid-handling-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","RVTY","BK4585","BK4121"],"gpt_icon":0},{"id":"2524246208","title":"BRIEF-Revvity Secures FDA Approval For Improved Automated Latent Tuberculosis Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2524246208","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524246208?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:00","pubTimestamp":1743595248,"startTime":"0","endTime":"0","summary":"BRIEF-Revvity Secures FDA Approval For Improved Automated Latent Tuberculosis TestApril 2 (Reuters) - Revvity Inc RVTY.N:REVVITY SECURES FDA APPROVAL FOR IMPROVED AUTOMATED LATENT TUBERCULOSIS TESTSou","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nTUA802NGV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVTY","BK4588","BK4585","BK4121"],"gpt_icon":0},{"id":"2524462702","title":"Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2524462702","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524462702?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:00","pubTimestamp":1743595203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nTUA802NGV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4588","BK4121","RVTY"],"gpt_icon":0},{"id":"2524346754","title":"Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2524346754","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524346754?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:00","pubTimestamp":1743595200,"startTime":"0","endTime":"0","summary":"FDA approves leading solution for latent tuberculosis diagnostics, advancing global effort to fight infectious diseases. WALTHAM, Mass., April 02, 2025----Revvity, Inc. , today announced that the U.S. Food and Drug Administration  has approved the Auto-Pure 2400 liquid handling platform with the T-SPOT.TB test. Initially launched outside the U.S. in 2024, this powerful combination allows laboratories to improve productivity while maintaining superior clinical performance in latent tuberculosis  detection. This milestone marks a significant advancement in the fight against TB with a faster high-throughput solution delivering accurate diagnostic results to support timely treatment and containment in the U.S. as well as other locations around the world.\"The integration of the Auto-Pure 2400 platform with the T-SPOT.TB test gives laboratories the ability to process latent TB tests at higher volumes without compromising clinical accuracy,\" said Yves Dubaquie, senior vice president, diagnost","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/revvity-secures-fda-approval-improved-120000223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","RVTY","BK4121","BK4585"],"gpt_icon":0},{"id":"2524491652","title":"Here's Why You Should Retain Revvity Stock in Your Portfolio for Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2524491652","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524491652?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:47","pubTimestamp":1743594420,"startTime":"0","endTime":"0","summary":"Revvity, Inc. RVTY is well-positioned for growth in the coming quarters, thanks to its strong product portfolio. The optimism, led by its solid fourth-quarter 2024 performance and focus on artificial intelligence , is expected to contribute further. Headwinds resulting from foreign exchange volatility and integration risks are major downsides.This Zacks Rank #3  company’s shares have lost 6.5% so far this year against the industry’s 4% growth. The S&P 500 has decreased 5.1% during the same time frame.The renowned provider of health science solutions has a market capitalization of $12.71 billion. It projects 6.1% growth over the next five years and expects to witness continued improvement in its business going further. Revvity’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average surprise of 7.48%.Meanwhile, the Revvity transcribed AI service automates handwritten data transcription in clinical labs, boosting workflow efficiency b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-retain-revvity-stock-114700572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1061106388.HKD","MASI","IE00B2B36J28.USD","LU0238689110.USD","LU1989771016.USD","LU2720916845.USD","COR","LU1585245621.USD","RVTY","BK4121","BK4504","BSX","BK4175","LU2087625088.SGD","LU2506952097.USD","LU2506952170.USD","IE00B4R5TH58.HKD","LU0240877869.USD","LU1430594728.SGD","BK4529","LU0950375773.USD","LU0882574055.USD","LU2764263203.CNY","LU0353189680.USD","BK4581","LU2491049909.HKD","LU1153585028.USD","LU0528227936.USD","SG9999004303.SGD","LU0267386448.USD","LU0205193047.USD","LU1261432733.SGD","LU2764263039.SGD","LU1718418525.SGD","LU0011850046.USD","LU2491050071.SGD","LU0345769631.USD","LU1291159041.SGD","LU0077335932.USD","LU0048584097.USD","BK4588","SGXZ23171101.USD","LU1989764664.SGD","LU0122379950.USD","LU0225283273.USD","LU0353189763.USD","LU1989764748.USD","LU0205194284.USD","LU1791710400.SGD"],"gpt_icon":0},{"id":"2524912449","title":"Revvity Inc. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2524912449","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524912449?lang=en_us&edition=fundamental","pubTime":"2025-04-02 05:16","pubTimestamp":1743542160,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Revvity Inc.  slipped 1.41% to $104.31 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.38% to 5,633.07 and the Dow Jones Industrial Average  falling 0.03% to 41,989.96.Revvity Inc. closed 19.45% short of its 52-week high of $129.50, which the company reached on November 6th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Danaher Corp.  fell 2.25% to $200.39, IDEXX Laboratories Inc.  fell 0.33% to $418.57, and Agilent Technologies Inc.  fell 2.30% to $114.05.Trading volume  remained 18,987 below its 50-day average volume of 999,261.Data source: Dow Jones Market Data, FactSet. Data compiled April 1, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVTY"],"gpt_icon":0},{"id":"2524132131","title":"Becton Dickinson in talks with Thermo Fisher, Danaher to divest life sciences unit, FT reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2524132131","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524132131?lang=en_us&edition=fundamental","pubTime":"2025-04-01 13:19","pubTimestamp":1743484747,"startTime":"0","endTime":"0","summary":"UPDATE 1-Becton Dickinson in talks with Thermo Fisher, Danaher to divest life sciences unit, FT reportsRewrites headline, adds details and background in paragraphs 2-6, stock movement in paragraph 3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL3N3QF0EF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU1670627923.USD","RVTY","LU0068578508.USD","LU1061106388.HKD","LU2089984988.USD","LU0820562030.AUD","LU0061474960.USD","LU0011850046.USD","GB00BDT5M118.USD","LU1894683264.USD","LU0096362180.USD","LU1923622291.USD","SG9999013999.USD","WAT","SGXZ57979304.SGD","LU0640476718.USD","LU0820561818.USD","LU2125909247.SGD","LU1923622614.USD","LU1153585028.USD","BK4585","SG9999004303.SGD","LU2112291526.USD","TMO","IE00B19Z9505.USD","LU1854104046.USD","SG9999001176.USD","IE00BJJMRZ35.SGD","BK4535","DHR","LU1291159041.SGD","LU2211814178.USD","IE0034235188.USD","LU0708995401.HKD","LU1064131342.USD","LU0689472784.USD","LU1712237335.SGD","LU0511384066.AUD","LU0878866978.SGD","IE00BFTCPJ56.SGD","LU0234572021.USD","IE00B19Z8W00.USD","LU2357305700.SGD","BDX","LU2265009873.SGD","BK4566","IE00B1BXHZ80.USD","BK4121","LU0985320562.USD"],"gpt_icon":0},{"id":"2523944010","title":"1 Healthcare Stock to Target This Week and 2 to Turn Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2523944010","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523944010?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:01","pubTimestamp":1743426113,"startTime":"0","endTime":"0","summary":"Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 11.1%. This drop was worse than the S&P 500’s 4% decline.Only some companies are subject to these dynamics, however, and a handful of high-quality businesses can deliver earnings growth in any environment. Taking that into account, here is one healthcare stock boasting a durable advantage and two that may face trouble.From its groundbreaking work in developing the first single-tablet regimens for HIV treatment, Gilead Sciences  develops and markets innovative medicines for life-threatening diseases including HIV, viral hepatitis, COVID-19, and cancer.At $109.50 per share, Gilead Sciences trades at 14.3x forward price-to-earnings. Check out our free in-depth research report to learn more about why GILD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/1-healthcare-stock-target-week-130153753.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2430703251.USD","LU2505996509.AUD","LU0058720904.USD","LU2129689514.USD","LU0098860793.USD","LU0320765992.SGD","LU1585245621.USD","IE00B19Z3581.USD","LU0289739699.SGD","LU2087621335.USD","GILD","LU0466842654.USD","LU2592432038.USD","SG9999002232.USD","LU1935042991.SGD","IE00BGHQF631.EUR","LU2129689431.USD","IE00B3T34201.USD","LU2112291526.USD","IE0009355771.USD","IE00BKVL7J92.USD","LU1221951046.USD","RVTY","HCSG","LU1261432733.SGD","BK4534","LU1061106388.HKD","LU1894683264.USD","BK4566","LU0795875169.SGD","LU0203345920.USD","IE00B2B36J28.USD","LU1023059063.AUD","LU1244550577.SGD","LU0792757196.USD","LU0234570918.USD","IE00B19Z3B42.SGD","LU1074936037.SGD","LU1894683348.USD","BK4592","LU0109394709.USD","LU1244550221.USD","LU1914381329.SGD","IE000M9KFDE8.USD","LU2129689605.HKD","SG9999001440.SGD","LU1778281490.HKD","JNJ","BK4550","BK4532"],"gpt_icon":0},{"id":"2522835435","title":"Revvity Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2522835435","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522835435?lang=en_us&edition=fundamental","pubTime":"2025-03-26 05:16","pubTimestamp":1742937360,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Revvity Inc.  slipped 1.11% to $107.38 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.16% to 5,776.65 and the Dow Jones Industrial Average  rising 0.01% to 42,587.50.The stock's fall snapped a two-day winning streak.Revvity Inc. closed 17.08% short of its 52-week high of $129.50, which the company achieved on November 6th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Danaher Corp.  fell 0.19% to $212.40, IDEXX Laboratories Inc.  fell 1.40% to $417.66, and Agilent Technologies Inc.  fell 1.20% to $120.51.Trading volume  eclipsed its 50-day average volume of 993,324.Data source: Dow Jones Market Data, FactSet. Data compiled March 25, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Do","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVTY"],"gpt_icon":0},{"id":"2522083412","title":"Revvity Inc. Stock Rises Monday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2522083412","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522083412?lang=en_us&edition=fundamental","pubTime":"2025-03-25 05:14","pubTimestamp":1742850840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Revvity Inc.  advanced 1.21% to $108.59 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 1.76% to 5,767.57 and the Dow Jones Industrial Average  rising 1.42% to 42,583.32.This was the stock's second consecutive day of gains.Revvity Inc. closed 16.15% below its 52-week high of $129.50, which the company achieved on November 6th.The stock outperformed some of its competitors Monday, as Danaher Corp.  rose 0.68% to $212.80, IDEXX Laboratories Inc.  rose 0.62% to $423.60, and Agilent Technologies Inc.  rose 1.01% to $121.97.Trading volume  remained 290,724 below its 50-day average volume of 993,310.Data source: Dow Jones Market Data, FactSet. Data compiled March 24, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVTY"],"gpt_icon":0},{"id":"2521258412","title":"Revvity Stock Tumbles Despite Expanding Genomics England Alliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2521258412","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521258412?lang=en_us&edition=fundamental","pubTime":"2025-03-22 00:53","pubTimestamp":1742575980,"startTime":"0","endTime":"0","summary":"Revvity, Inc. RVTY recently announced an expanded collaboration with Genomics England to further collaborate on theGeneration Study, a research focused on newborn genomic sequencing. This partnership is set to play a vital role in advancing the integration of whole genome sequencing within newborn screening programs, aiming to identify rare and genetic conditions earlier in life.By combining Revvity’s expertise in genomic technologies with Genomics England’s large-scale research initiatives, the alliance aspires to transform early healthcare interventions and pave the way for more personalized, preventative treatments for newborns.The Generation Study, part of Genomics England's Newborn Genomes Programme, is a large-scale research initiative aiming to sequence the genomes of 100,000 newborns in England. Its goal is to evaluate whether whole genome sequencing can enhance routine newborn screening by detecting rare, actionable genetic conditions early in life. The study also focuses on g","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/revvity-stock-tumbles-despite-expanding-165300298.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BFTCPJ56.SGD","LU0823417737.USD","LU1791710400.SGD","LU1291159041.SGD","LU1804176565.USD","LU0353189680.USD","SG9999001440.SGD","MASI","LU0345769128.USD","LU1989772840.SGD","LU2506951958.HKD","LU2506952097.USD","LU1880398471.USD","LU0889566641.SGD","LU2362540622.SGD","LU0267386448.USD","LU0122379950.USD","IE0009355771.USD","LU0353189763.USD","BSX","LU1989764664.SGD","LU0251132253.USD","LU0211327993.USD","BK4082","LU0950375773.USD","LU2324357040.USD","LU2491049909.HKD","RVTY","LU2244417387.USD","LU1989772923.USD","LU2362541273.HKD","IE00B4R5TH58.HKD","LU0792757196.USD","CAH","BK4581","LU1061106388.HKD","LU2506951875.HKD","LU0823417653.USD","LU1267930227.SGD","LU1989771016.USD","LU0011850046.USD","LU2242649171.HKD","LU1267930813.SGD","IE00BJJMRZ35.SGD","BK4175","LU0211328371.USD","LU1791710582.SGD","LU1983299246.USD","LU0823416689.USD"],"gpt_icon":0},{"id":"2521846058","title":"Revvity Expands Alliance with Genomics England","url":"https://stock-news.laohu8.com/highlight/detail?id=2521846058","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521846058?lang=en_us&edition=fundamental","pubTime":"2025-03-21 02:09","pubTimestamp":1742494182,"startTime":"0","endTime":"0","summary":"Revvity  said Thursday it has signed a new agreement with Genomics England to further collaborate on the Generation Study, a national initiative to screen up to 100,000 newborns for more than 200 rare genetic disorders.Under the new contract, Revvity said it will also provide DNA sequencing services to help screen newborns for rare genetic conditions, adding to its previous DNA extraction services.The firm said it will now be able to provide an end-to-end solution with a localized lab facility to advance the screening process.Price: 107.11, Change: -2.81, Percent Change: -2.56","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","RVTY","BK4588","BK4121"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":191,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RVTY\",params:#limit:5,,,undefined,":[{"date":"2025-07-18","symbol":"RVTY","amount":0.07,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-18","defaultRemindTime":1752845400000,"name":"REVVITY INC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-08","payableDate":"2025-07-18","currency":"USD","dateTimestamp":1752811200000,"payDate":"2025-08-08"},{"market":"US","date":"2025-04-28","symbol":"RVTY","fiscalQuarterEnding":"2025/03","expectedEps":0.96,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745812800000,"reportTimeType":"pre","actualEps":1.01},{"date":"2025-04-17","symbol":"RVTY","amount":0.07,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-18","defaultRemindTime":1744896600000,"name":"REVVITY INC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-09","payableDate":"2025-04-18","currency":"USD","dateTimestamp":1744862400000,"payDate":"2025-05-09"},{"market":"US","date":"2025-01-31","symbol":"RVTY","fiscalQuarterEnding":"2024/12","expectedEps":1.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738299600000,"reportTimeType":"pre","actualEps":1.42},{"date":"2025-01-17","symbol":"RVTY","amount":0.07,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-01-17","defaultRemindTime":1737124200000,"name":"REVVITY INC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-07","payableDate":"2025-01-17","currency":"USD","dateTimestamp":1737090000000,"payDate":"2025-02-07"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RVTY\",market:\"US\",,,undefined,":[{"executeDate":"2015-07-15","recordDate":"2015-07-17","paymentDate":"2015-08-10","value":0.07,"currency":"USD"},{"executeDate":"2015-10-14","recordDate":"2015-10-16","paymentDate":"2015-11-10","value":0.07,"currency":"USD"},{"executeDate":"2016-01-13","recordDate":"2016-01-15","paymentDate":"2016-02-10","value":0.07,"currency":"USD"},{"executeDate":"2016-04-13","recordDate":"2016-04-15","paymentDate":"2016-05-10","value":0.07,"currency":"USD"},{"executeDate":"2016-07-13","recordDate":"2016-07-15","paymentDate":"2016-08-10","value":0.07,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RVTY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.35,"hold":0.35,"sell":0.05,"strongSell":0,"meanLabel":"BUY","meanPercent":0.35,"analysts":20,"updateTime":1747022400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RVTY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RVTY","date":"2025-06-17","current":39.624512,"percent":0.481557,"low":13.728284,"twenty":17.255123,"median":41.334026,"eighty":86.46751,"high":94.957649,"avg":46.218375,"sd":29.248814,"marketCap":11356741741},"quantilePoints":[{"date":"2023-05-19","current":15.240354,"twenty":15.118264,"median":15.240354,"eighty":21.198544,"marketCap":14656526673},{"date":"2023-05-26","current":15.189483,"twenty":15.189483,"median":15.462098,"eighty":15.691669,"marketCap":14607604682},{"date":"2023-06-02","current":15.087742,"twenty":15.078611,"median":15.203831,"eighty":15.685408,"marketCap":14509760701},{"date":"2023-06-09","current":14.537294,"twenty":15.032175,"median":15.159483,"eighty":15.506447,"marketCap":13980399672},{"date":"2023-06-16","current":15.348618,"twenty":14.952869,"median":15.070133,"eighty":15.305312,"marketCap":14760642705},{"date":"2023-06-23","current":15.038176,"twenty":14.995653,"median":15.070133,"eighty":15.326965,"marketCap":14462093120},{"date":"2023-06-30","current":15.460794,"twenty":15.029045,"median":15.134699,"eighty":15.348618,"marketCap":14868521967},{"date":"2023-07-07","current":15.115134,"twenty":15.033741,"median":15.142526,"eighty":15.35227,"marketCap":14536103311},{"date":"2023-07-14","current":15.949936,"twenty":15.037654,"median":15.181005,"eighty":15.485316,"marketCap":15338925724},{"date":"2023-07-21","current":16.530384,"twenty":15.039219,"median":15.220789,"eighty":15.688539,"marketCap":15897138183},{"date":"2023-07-28","current":16.778216,"twenty":15.041306,"median":15.258615,"eighty":15.991415,"marketCap":16135476087},{"date":"2023-08-04","current":18.887325,"twenty":15.046263,"median":15.320574,"eighty":16.679083,"marketCap":15450568216},{"date":"2023-08-11","current":18.34163,"twenty":15.066611,"median":15.460794,"eighty":17.025526,"marketCap":15004168441},{"date":"2023-08-18","current":17.371968,"twenty":15.098699,"median":15.619929,"eighty":17.833278,"marketCap":14210947324},{"date":"2023-08-25","current":17.632972,"twenty":15.11983,"median":15.741235,"eighty":17.720378,"marketCap":14424459112},{"date":"2023-09-01","current":17.758922,"twenty":15.133134,"median":15.984502,"eighty":17.849667,"marketCap":14527490962},{"date":"2023-09-08","current":16.725527,"twenty":15.142526,"median":16.446904,"eighty":17.810516,"marketCap":13682133247},{"date":"2023-09-15","current":17.103376,"twenty":15.159483,"median":16.4756,"eighty":17.769544,"marketCap":13991228799},{"date":"2023-09-22","current":16.463005,"twenty":15.1647,"median":16.483651,"eighty":17.765295,"marketCap":13467380112},{"date":"2023-09-29","current":16.730079,"twenty":15.175917,"median":16.530079,"eighty":17.736464,"marketCap":13685857290},{"date":"2023-10-06","current":16.176204,"twenty":15.186092,"median":16.529774,"eighty":17.669088,"marketCap":13232765416},{"date":"2023-10-13","current":16.01687,"twenty":15.200962,"median":16.517035,"eighty":17.641167,"marketCap":13102423918},{"date":"2023-10-20","current":15.391673,"twenty":15.220267,"median":16.446904,"eighty":17.556492,"marketCap":12590988706},{"date":"2023-10-23","current":15.428092,"twenty":15.22131,"median":16.40336,"eighty":17.518251,"marketCap":12620781049},{"date":"2023-11-02","current":13.805221,"twenty":15.179309,"median":16.350713,"eighty":17.430845,"marketCap":10246083090},{"date":"2023-11-10","current":13.993683,"twenty":15.142526,"median":16.318846,"eighty":17.414457,"marketCap":10385957358},{"date":"2023-11-17","current":14.665433,"twenty":15.080698,"median":16.176204,"eighty":17.380466,"marketCap":10884522801},{"date":"2023-11-24","current":14.979692,"twenty":15.039741,"median":16.062394,"eighty":17.330086,"marketCap":11117762575},{"date":"2023-12-01","current":14.781825,"twenty":15.004001,"median":16.019068,"eighty":17.294273,"marketCap":10970907903},{"date":"2023-12-08","current":15.244069,"twenty":15.004001,"median":15.949936,"eighty":17.255123,"marketCap":11313980163},{"date":"2023-12-15","current":16.845295,"twenty":14.995653,"median":15.845585,"eighty":17.208992,"marketCap":12502392347},{"date":"2023-12-20","current":17.413954,"twenty":15.004001,"median":15.949936,"eighty":17.255123,"marketCap":12924445272},{"date":"2023-12-29","current":18.418254,"twenty":15.012349,"median":15.949936,"eighty":17.290328,"marketCap":13669825291},{"date":"2024-01-05","current":17.911116,"twenty":15.03061,"median":16.01687,"eighty":17.405557,"marketCap":13293433063},{"date":"2024-01-12","current":18.42823,"twenty":15.037132,"median":16.046461,"eighty":17.598812,"marketCap":13677229729},{"date":"2024-01-19","current":17.611821,"twenty":15.038176,"median":16.173169,"eighty":17.64663,"marketCap":13071299944},{"date":"2024-01-26","current":18.072402,"twenty":15.040784,"median":16.318846,"eighty":17.769544,"marketCap":13413138132},{"date":"2024-02-02","current":19.454043,"twenty":15.042089,"median":16.364528,"eighty":17.872873,"marketCap":13483480286},{"date":"2024-02-09","current":18.383946,"twenty":15.052524,"median":16.463005,"eighty":18.033584,"marketCap":12741802486},{"date":"2024-02-16","current":18.529949,"twenty":15.071143,"median":16.530079,"eighty":18.072402,"marketCap":12842996462},{"date":"2024-02-23","current":18.583365,"twenty":15.077794,"median":16.557088,"eighty":18.252672,"marketCap":12880018648},{"date":"2024-03-01","current":19.532175,"twenty":15.086085,"median":16.725527,"eighty":18.345648,"marketCap":13537633083},{"date":"2024-03-08","current":19.336122,"twenty":15.109656,"median":16.788291,"eighty":18.419252,"marketCap":13401750280},{"date":"2024-03-15","current":18.691957,"twenty":15.124525,"median":16.845295,"eighty":18.475109,"marketCap":12955283226},{"date":"2024-03-22","current":18.725819,"twenty":15.132836,"median":16.92194,"eighty":18.501855,"marketCap":12978752942},{"date":"2024-03-28","current":18.786415,"twenty":15.139246,"median":16.970858,"eighty":18.503982,"marketCap":13020751381},{"date":"2024-04-05","current":18.121646,"twenty":15.1527,"median":17.103376,"eighty":18.503982,"marketCap":12560003799},{"date":"2024-04-12","current":19.337122,"twenty":15.167309,"median":17.201253,"eighty":18.559449,"marketCap":13402443078},{"date":"2024-04-19","current":17.711734,"twenty":15.175546,"median":17.302164,"eighty":18.540632,"marketCap":12275896710},{"date":"2024-04-26","current":18.194717,"twenty":15.184713,"median":17.414206,"eighty":18.518197,"marketCap":12610648975},{"date":"2024-05-03","current":83.443975,"twenty":15.206701,"median":17.462174,"eighty":18.572896,"marketCap":12485888906},{"date":"2024-05-10","current":86.043257,"twenty":15.22131,"median":17.622397,"eighty":18.663099,"marketCap":12874824680},{"date":"2024-05-17","current":89.440787,"twenty":15.233571,"median":17.696621,"eighty":18.718334,"marketCap":13383203803},{"date":"2024-05-24","current":92.269312,"twenty":15.242583,"median":17.75105,"eighty":18.814113,"marketCap":13806441762},{"date":"2024-05-31","current":90.100501,"twenty":15.24939,"median":17.772989,"eighty":18.873831,"marketCap":13481918196},{"date":"2024-06-07","current":91.469409,"twenty":15.257869,"median":17.851257,"eighty":19.02926,"marketCap":13686750561},{"date":"2024-06-14","current":89.597469,"twenty":15.260702,"median":17.87432,"eighty":19.130089,"marketCap":13406648472},{"date":"2024-06-21","current":89.044958,"twenty":15.269572,"median":17.915685,"eighty":19.244446,"marketCap":13323975168},{"date":"2024-06-28","current":86.472072,"twenty":15.303747,"median":17.975503,"eighty":19.382462,"marketCap":12938989036},{"date":"2024-07-05","current":85.400036,"twenty":15.348618,"median":18.033584,"eighty":19.485835,"marketCap":12778578147},{"date":"2024-07-12","current":90.314908,"twenty":15.357748,"median":18.052552,"eighty":83.055979,"marketCap":13514000374},{"date":"2024-07-19","current":89.185147,"twenty":15.391673,"median":18.121646,"eighty":84.575393,"marketCap":13344951976},{"date":"2024-07-26","current":94.957649,"twenty":15.414435,"median":18.176268,"eighty":84.880387,"marketCap":14208702913},{"date":"2024-08-02","current":89.773858,"twenty":15.428092,"median":18.228579,"eighty":85.771125,"marketCap":15210654000},{"date":"2024-08-09","current":86.44263,"twenty":15.460794,"median":18.242169,"eighty":86.29065,"marketCap":14646234075},{"date":"2024-08-16","current":87.105053,"twenty":15.5221,"median":18.299868,"eighty":86.422593,"marketCap":14758470479},{"date":"2024-08-23","current":88.262475,"twenty":15.556014,"median":18.331629,"eighty":86.69654,"marketCap":14954575845},{"date":"2024-08-30","current":89.201514,"twenty":15.683843,"median":18.36172,"eighty":87.041075,"marketCap":15113680198},{"date":"2024-09-06","current":84.011317,"twenty":15.690104,"median":18.388671,"eighty":87.053871,"marketCap":14234289470},{"date":"2024-09-13","current":88.830266,"twenty":15.731322,"median":18.411637,"eighty":87.206013,"marketCap":15050778477},{"date":"2024-09-20","current":89.456293,"twenty":15.908196,"median":18.42823,"eighty":87.527963,"marketCap":15156848046},{"date":"2024-09-27","current":91.763856,"twenty":15.949936,"median":18.441685,"eighty":88.002489,"marketCap":15547825410},{"date":"2024-10-04","current":90.235186,"twenty":16.003483,"median":18.474753,"eighty":88.22171,"marketCap":15288818323},{"date":"2024-10-11","current":88.451738,"twenty":16.018628,"median":18.493053,"eighty":88.451738,"marketCap":14986643389},{"date":"2024-10-18","current":87.112333,"twenty":16.028235,"median":18.510363,"eighty":88.456581,"marketCap":14759703846},{"date":"2024-10-25","current":84.68102,"twenty":16.056021,"median":18.560147,"eighty":88.451738,"marketCap":14347759241},{"date":"2024-11-01","current":88.109608,"twenty":16.148586,"median":18.577895,"eighty":88.323621,"marketCap":14928675136},{"date":"2024-11-08","current":58.61064,"twenty":16.17499,"median":18.625179,"eighty":88.268298,"marketCap":14904861698},{"date":"2024-11-15","current":52.413141,"twenty":16.204125,"median":18.691957,"eighty":88.22171,"marketCap":13328818920},{"date":"2024-11-22","current":53.614355,"twenty":16.297298,"median":18.719582,"eighty":88.165779,"marketCap":13634291304},{"date":"2024-11-29","current":55.581283,"twenty":16.332503,"median":18.795467,"eighty":88.14934,"marketCap":14134487120},{"date":"2024-12-06","current":55.734426,"twenty":16.352533,"median":18.826386,"eighty":88.124166,"marketCap":14173431806},{"date":"2024-12-13","current":55.485569,"twenty":16.36547,"median":18.870457,"eighty":88.096505,"marketCap":14110146691},{"date":"2024-12-20","current":53.867998,"twenty":16.415838,"median":18.898059,"eighty":88.023809,"marketCap":13698793441},{"date":"2024-12-27","current":53.595212,"twenty":16.453344,"median":19.072342,"eighty":87.94228,"marketCap":13629423218},{"date":"2025-01-03","current":54.365712,"twenty":16.471263,"median":19.091948,"eighty":87.877003,"marketCap":13825363672},{"date":"2025-01-10","current":54.499712,"twenty":16.504297,"median":19.132941,"eighty":87.849226,"marketCap":13859440272},{"date":"2025-01-17","current":56.658069,"twenty":16.529774,"median":19.2391,"eighty":87.530786,"marketCap":14408316946},{"date":"2025-01-24","current":58.936069,"twenty":16.530262,"median":19.336622,"eighty":87.527963,"marketCap":14987619156},{"date":"2025-01-31","current":56.771979,"twenty":16.544463,"median":19.393156,"eighty":87.521434,"marketCap":15350291548},{"date":"2025-02-07","current":53.499702,"twenty":16.562551,"median":19.477815,"eighty":87.49086,"marketCap":14465516954},{"date":"2025-02-14","current":50.528997,"twenty":16.675451,"median":19.732775,"eighty":87.466111,"marketCap":13662282797},{"date":"2025-02-21","current":51.240166,"twenty":16.716422,"median":50.083391,"eighty":87.409331,"marketCap":13854572186},{"date":"2025-02-28","current":49.851153,"twenty":16.728258,"median":50.189166,"eighty":87.37439,"marketCap":13479004124},{"date":"2025-03-07","current":52.255922,"twenty":16.758961,"median":50.083391,"eighty":87.352552,"marketCap":14129217342},{"date":"2025-03-14","current":49.727917,"twenty":16.790305,"median":49.967272,"eighty":87.239008,"marketCap":13445682776},{"date":"2025-03-21","current":47.674991,"twenty":16.814754,"median":49.851153,"eighty":87.16718,"marketCap":12890602314},{"date":"2025-03-28","current":46.932915,"twenty":16.837449,"median":49.60954,"eighty":87.132715,"marketCap":12689956347},{"date":"2025-04-04","current":42.142754,"twenty":16.878615,"median":49.068826,"eighty":87.107965,"marketCap":11394768604},{"date":"2025-04-11","current":42.151641,"twenty":16.905815,"median":48.705092,"eighty":87.066666,"marketCap":11397171549},{"date":"2025-04-17","current":40.800798,"twenty":16.91938,"median":47.983818,"eighty":87.020078,"marketCap":11031923800},{"date":"2025-04-25","current":41.898358,"twenty":16.944133,"median":47.697208,"eighty":86.956554,"marketCap":11328687596},{"date":"2025-05-02","current":39.400868,"twenty":16.96833,"median":47.479473,"eighty":86.867746,"marketCap":11292643411},{"date":"2025-05-09","current":37.527107,"twenty":17.018256,"median":46.932915,"eighty":86.771658,"marketCap":10755606475},{"date":"2025-05-16","current":38.353731,"twenty":17.083589,"median":44.899985,"eighty":86.710164,"marketCap":10992524491},{"date":"2025-05-23","current":37.210439,"twenty":17.134332,"median":42.729305,"eighty":86.688152,"marketCap":10664846836},{"date":"2025-05-30","current":37.798535,"twenty":17.182284,"median":42.271618,"eighty":86.672658,"marketCap":10833400450},{"date":"2025-06-06","current":37.218665,"twenty":17.193513,"median":42.020556,"eighty":86.623223,"marketCap":10667204230},{"date":"2025-06-13","current":39.357196,"twenty":17.227808,"median":41.627301,"eighty":86.470551,"marketCap":11280126462},{"date":"2025-06-17","current":39.624512,"twenty":17.255123,"median":41.334026,"eighty":86.46751,"marketCap":11356741741}],"updateTime":1750267797457}}}